(Shanghai Comprehensive News) The Chinese medical anti -corruption continued to deepen, and Cheng Yingsheng, the dean of Tongji Hospital of Shanghai Third -level Hospital, was investigated.
According to the WeChat signal "Integrity Shanghai" of the Shanghai Disciplinary Inspection Commission of the Communist Party of China on Monday (June 24), Cheng Yingsheng, deputy secretary of the Party Committee and Dean of Shanghai Tongji Hospital, is suspected of serious disciplinary violations.And the Shanghai Hongkou District Supervision Committee disciplined and supervisory investigation.
Public information shows that Cheng Yingsheng is an expert in Chinese radiology department and enjoys special allowances of the State Council. In 2018, he was rated as the master of China Interactive Intervention and was transferred to the Dean of Tongji Hospital at the end of 2021.He has won the May 1st Labor Medal in Shanghai in 2023.
Since last year, China has accelerated anti -corruption in the medical field.In August of the National Health and Health Commission of China, in August last year, it requested the prominent corruption of the pharmaceutical industry to carry out systematic governance in the entire field, full -chain, and full coverage.
In late May of this year, the 14 departments of the National Health and Health Commission of China issued the notification of unrequited work points in the field of medical purchase and sales and medical services in late May, and required to focus on medical institutions such as "famous hospitals" and "famous doctors".The management of "key minority" and personnel of key positions focuses on punishing themselves or instructions to relatives and friends, and uses business -based business companies to "take medicine and take medicine" and receive supplier rebates.
According to the incomplete statistics of Chinanews.com, as of June 18, at least 150 medical and health system personnel have been investigated this year, covering the "first leaders" in the fields of local health, medical insurance, drug supervision, and hospitals and pharmaceutical companies., College management.Among these investigators, at least 19 hall -level cadres.
